BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38409850)

  • 21. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.
    Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P
    Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of ovarian carcinomas.
    Diebold J
    Histol Histopathol; 1999 Jan; 14(1):269-77. PubMed ID: 9987671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ki-ras gene mutations are invariably present in low-grade mucinous tumors of the vermiform appendix.
    Zauber P; Berman E; Marotta S; Sabbath-Solitare M; Bishop T
    Scand J Gastroenterol; 2011 Jul; 46(7-8):869-74. PubMed ID: 21443421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
    Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL
    Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Aoki T; Murakami M; Mizukami H; Tanaka JI; Takimoto M
    Anticancer Res; 2017 Dec; 37(12):7063-7068. PubMed ID: 29187496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive immunohistochemical analysis of the gastrointestinal and Müllerian phenotypes of 139 ovarian mucinous cystadenomas.
    Halimi SA; Maeda D; Ushiku-Shinozaki A; Goto A; Oda K; Osuga Y; Fujii T; Ushiku T; Fukayama M
    Hum Pathol; 2021 Mar; 109():21-30. PubMed ID: 33275953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.
    Kim KR; Choi J; Hwang JE; Baik YA; Shim JY; Kim YM; Robboy SJ
    Histopathology; 2010 Oct; 57(4):587-96. PubMed ID: 20955384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix.
    Yantiss RK; Panczykowski A; Misdraji J; Hahn HP; Odze RD; Rennert H; Chen YT
    Am J Surg Pathol; 2007 Nov; 31(11):1742-53. PubMed ID: 18059232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
    Nikiforova MN; Khalid A; Fasanella KE; McGrath KM; Brand RE; Chennat JS; Slivka A; Zeh HJ; Zureikat AH; Krasinskas AM; Ohori NP; Schoedel KE; Navina S; Mantha GS; Pai RK; Singhi AD
    Mod Pathol; 2013 Nov; 26(11):1478-87. PubMed ID: 23743931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
    Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy.
    Favazza LA; Parseghian CM; Kaya C; Nikiforova MN; Roy S; Wald AI; Landau MS; Proksell SS; Dueker JM; Johnston ER; Brand RE; Bahary N; Gorantla VC; Rhee JC; Pingpank JF; Choudry HA; Lee K; Paniccia A; Ongchin MC; Zureikat AH; Bartlett DL; Singhi AD
    Mod Pathol; 2020 Sep; 33(9):1832-1843. PubMed ID: 32376853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.
    Ryland GL; Hunter SM; Doyle MA; Rowley SM; Christie M; Allan PE; Bowtell DD; ; Gorringe KL; Campbell IG
    J Pathol; 2013 Feb; 229(3):469-76. PubMed ID: 23096461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
    Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
    Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
    Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
    Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucinous Cystadenoma of the Urachus and Review of Current Classification of Urachal Mucinous Cystic Neoplasms.
    Wang D; Sule N
    Arch Pathol Lab Med; 2019 Feb; 143(2):258-263. PubMed ID: 30398914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of appendiceal mucinous neoplasms with a new classification system and literature review.
    Gündoğar Ö; Kımıloğlu E; Komut N; Cin M; Bektaş S; Gönüllü D; İlgün AS; Erdoğan N
    Turk J Gastroenterol; 2018 Sep; 29(5):533-542. PubMed ID: 30260774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.